
CG Oncology, Inc. Common stock
CG Oncology, Inc. Common stock (CGON) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CGON · as of Jun 8, 2026
Key Statistics
Explore CG Oncology, Inc. Common stock Data
cgon stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The CGON analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $82.57, representing +53.70% upside from the current price of $53.72.
Competitors & Peers
cgon competitorsStock Performance
Full HistoryAbout CG Oncology, Inc. Common stock
CG Oncology, Inc. Common stock CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their pro…
what is cg oncology, inc. common stock · cgon stock overview · cg oncology, inc. common stock company profile · who is cg oncology, inc. common stock ceo · cgon NASDAQ · cg oncology, inc. common stock headquarters · cg oncology, inc. common stock business segments
About Stock Overview & Key Data
CG Oncology, Inc. Common stock (CGON) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 25, 2024. As of the latest trading session, CGON stock price is $53.72, with a market capitalization of $4.7B. The stock has returned +98.96% over the past 12 months and +29.38% year-to-date.
According to 10 Wall Street analysts, the consensus rating for CG Oncology, Inc. Common stock stock is Buy, with an average 12-month price target of $82.57. In fiscal year 2025, CG Oncology, Inc. Common stock reported revenue of $4.0M and net income of -$161.0M. For detailed data — including CG Oncology, Inc. Common stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CG Oncology, Inc. Common stock (CGON) stock price is $53.72. The stock is traded on NASDAQ under the ticker symbol CGON. The 52-week range is $23.65 – $75.50.